Abstract
The human growth hormone (GH) transient gene expression assay system is frequently used to monitor transfection efficiency in transient transfection experiments. In this paper, we analyzed the suitability of the GH reporter gene to monitor transfection effciency in COS-7 cells of an expression vector carrying the cDNA for the normal and mutated human follicle-stimulating hormone receptor (FSHR). The FSHR cDNA was cloned in the pSG5 expression vector and mutagenized (Ala307→Thr) by oligonucleotide-mediated, site-directed mutagenesis. The expression plasmid pXGH5, carrying the structural gene for human GH, was used to monitor transfection efficiency. Different concentrations of pXGH5 and pSG5 containing normal or mutated FSHR cDNA were transfected in COS-7 cells by lipofection. The results showed: 1) The expression of pXGH5 was constant within individual experiments, but only in culture wells cotransfected with the same type of FSHR construct. On the contrary, the GH values normalized by the cell densities changed consistently depending on the type of FSHR construct. 2) The expression of the GH plasmid was influenced by type and concentration of the cotransfected plasmid. 3) The expression of pXGH5 cotransfected with the same FSHR construct was quite variable between experiments, without any relationship to the type of FSHR construct. These data show that the GH secretion is not a good parameter to monitor the transfection efficiency of the FSHR in pSG5 in COS-7 cells. Nor are other parameters such as semiquantitative mRNA determination or ligand binding to the transfected receptor ideal when mutations resulting in changes in receptor function are expected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Minegishi T., Nakamura K., Takakura Y., Ibuki Y., Igarashi M. Cloning and sequencing of human FSH receptor cDNA. Biochem. Biophys. Res. Commun. 175: 1125, 1991.
Tilly J.L., Aihara T., Nishimori K., Jia X.C., Billig H., Kowalski K.I., Perlas E.A., Hsueh A.J.W. Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 131: 799, 1992.
Shenker A., Laue L., Kosugi S., Merendino J. J. Jr, Minegishi T., Cutler G.B. Jr A constitutively activating mutation of the luteinizing hormone receptor in familial precocious puberty. Nature 365: 652, 1993.
Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649, 1993.
Aittomäki K., Dieguez Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E.-M., Lehväslaiho H., Engel A.R., Nieschlag E., Huhtaniemi I., de la Chapelle A. Mutation in the follicle-stumulating hormone receptor gene causes hereditary hypogonadotropic ovarian failure. Cell 82: 959, 1995.
Sciden R.F. Assay for human growth hormone. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Scidman J.G., Smith J.A., Struhl K. (Eds.), Current Protocols in Molecular Biology. Current Protocols, Brooklyn, 1993, p. 9.7.1
Gromoll J., Gudermann T., Nieschlag E. Molecular cloning of a truncated isoform of the human follicle stimulating hormone receptor. Biochem. Biophys. Res. Commun. 188: 1077, 1992.
Whitt M., Buonocore L., Rose J.K. Liposome-mediated transfection. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. (Eds.), Current Protocols in Molecular Biology. Current Protocols, Brooklyn, 1993, p. 9-4-1
Brooker G., Harper J.F., Tarasahi W.L., Moylan R.D. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cycl. Nucl. Res. 10: 1, 1979.
Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248, 1976.
Kosugi S., Okajima F., Ban T., Hidaka A., Shenker A., Kohn L.D. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but nor cAMP signal induced by TSH and receptor antibodies. J. Biol. Chem. 267: 24153, 1992.
Sciden R.F., Burke Howie K., Rowe M.E., Goodman H.M., Moore D.D. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6: 3173, 1986.
Larsen P.R., Harney J.W., Moore D.D. Sequences required for cell-type specific thyroid hormone regulation of rat growth hormone promoter activity. J. Biol. Chem. 261: 14373, 1986.
Kosugi S., Okajiama F., Ban T., Hidaka A., Shenker A., Kohn LD. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3′,5′-cyclic adenosine monophosphate signal generation. Mol. Endocrinol. 7: 1009, 1993.
Duprez L., Parma J., Van Sande J., Allgeier A., Leclère J., Schvartz C., Delisle M.-J., Decoulx M., Orgiazzi J., Dumont J., Vassart G. Germline mutations in the thyrotropin receptor gene cause nonimmune autosomal hyperthyroidism. Nature Genetics 7: 396, 1994.
Pavlakis G.N., Harmer D.H. Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus. Proc. Natl. Acad. Sci. USA 80: 397, 1983.
Alam J., Cook J.L. Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem. 188: 245, 1990.
Zhu X., Gilbert S., Birnbaumer M., Birnbaumer L. Dual signal potential is common among Gs-coupled receptors and dependent on receptor density. Mol. Pharmacol. 46: 460, 1994.
Dirks W., Wirth M., Hauser H. Dicistronic transcription units for gene expression in mammalian cells. Gene 128: 247, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simoni, M., Gromoll, J. Monitoring the transfection efficiency of the human folliclestimulating hormone receptor cDNA in COS-7 cells: evaluation of the growth hormone transient gene expression assay system. J Endocrinol Invest 19, 359–364 (1996). https://doi.org/10.1007/BF03344970
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344970